Proactive Research analyst Richard Jeans presents his research on biotech investor NetScientific PLC.
Jeans says the company is well positioned to benefit from a recovery in the life sciences and technology sectors.
He talks through its portfolio of investments, including many that are already generating sales and several others that are in late-stage clinical trials.
source